BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2755878)

  • 1. Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activity.
    Raffa RB
    Peptides; 1989; 10(2):403-6. PubMed ID: 2755878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraspinal administration of [D-Met2]FMRFamide produces a naloxone-sensitive increase in heart rate in unrestrained spontaneously hypertensive rats.
    Raffa RB; Addo MF; Gill A
    Neuropeptides; 1992 Apr; 21(4):201-5. PubMed ID: 1355596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice.
    Jacoby MB; Jacoby HI; Mathiasen JR; Raffa RB
    Neurosci Lett; 1987 Dec; 83(1-2):128-32. PubMed ID: 3441291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice.
    Raffa RB; Jacoby HI
    Peptides; 1989; 10(4):873-5. PubMed ID: 2587427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
    Raffa RB; Connelly CD
    Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Phe-D-Met-Arg-Phe-NH2 and other Phe-Met-Arg-Phe-NH2-related peptides on mouse colonic propulsive motility: a structure-activity relationship study.
    Raffa RB; Jacoby HI
    J Pharmacol Exp Ther; 1990 Sep; 254(3):809-14. PubMed ID: 1975622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice.
    Kavaliers M
    Neurosci Lett; 1990 Jul; 115(2-3):307-12. PubMed ID: 2234508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers inhibit the antagonistic effects of Phe-Met-Arg-Phe-amide (FMRFamide) on morphine- and stress-induced analgesia in mice.
    Kavaliers M
    Brain Res; 1987 Jul; 415(2):380-4. PubMed ID: 2440527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 1993 Jun; 237(1):73-81. PubMed ID: 8102975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal FMRFamide (Phe-Met-Arg-Phe-NH2) induces excessive grooming behavior in mice.
    Raffa RB; Heyman J; Porreca F
    Neurosci Lett; 1986 Mar; 65(1):94-8. PubMed ID: 2422608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Brain Res; 1993 Aug; 619(1-2):163-72. PubMed ID: 8374774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMRFamide suppresses kappa opiate induced feeding in the mouse.
    Kavaliers M; Hirst M
    Peptides; 1985; 6(5):847-9. PubMed ID: 3001666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and activity.
    Kavaliers M; Hirst M
    Brain Res; 1986 May; 372(2):370-4. PubMed ID: 2871903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick test.
    Raffa RB; Connelly CD
    NIDA Res Monogr; 1990; 105():391-2. PubMed ID: 1876049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice.
    Kavaliers M; Yang HY
    Peptides; 1989; 10(4):741-5. PubMed ID: 2587416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of FMRF-NH2 and FMRF-NH2 related peptides on mammals.
    Raffa RB
    NIDA Res Monogr; 1990; 105():243-9. PubMed ID: 1678861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat.
    Baumeister AA; Anticich TG; Hawkins MF; Liter JC; Thibodeaux HF; Guillory EC
    Brain Res; 1988 Apr; 447(1):116-21. PubMed ID: 3382946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could dual G-protein coupling explain [D-Met2]FMRFamide's mixed action in vivo?
    Raffa RB; Stone DJ
    Peptides; 1996; 17(8):1261-5. PubMed ID: 8971917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.